Highlights
- 1Nature communications · 2023
- 2
- 3Nature communications · 2025
Publications
Funding
Active
4 grants- PIR01HD120978-01Deriving Real World Insights to Inform Trials for Pregnant Individuals Using Electronic Health Records and Machine LearningEunice Kennedy Shriver National Institute of Child Health and Human Development · 2026–2031
- Co-IOT2OD040511-01AR² - Autism Replication, Validation, and Reproducibility CenterOffice of the Director, NIH · 2025–2028
- Co-IOT2OD038083-01Heart Failure Endotypes from Ethical, Multi-Modal AI driven and Molecular/Phenotypic Data Integration Enabled DiscoveryOffice of the Director, NIH · 2025–2026 · via Northwestern University
- KPOT2HL161847-01PASC EHR/ORWD Phase II Proposal (RECOVER) Year 5National Heart, Lung, and Blood Institute · 2023–2026 · via New York University School of Medicine (Grossman)· 3 renewals
News mentions
- AI Research Team Could Streamline Clinical Trial DesignJuly 7, 2026
An artificial intelligence system that operates like a collaborative team of medical experts could accelerate clinical trial design, one of the most difficult steps in drug development, according to a new study by Weill Cornell Medicine investigators.
- Pregnancy May Reduce Long COVID RiskApril 1, 2025
A multi-institutional study co-led by Weill Cornell Medicine finds that pregnancy may offer some protection from developing Long COVID— a condition lasting for months after a person recovers from SARS-CoV-2 infection.
- Study Discovers Long COVID Risk and Symptoms Vary in Different PopulationsMay 9, 2023
While the peak of the COVID-19 pandemic seems to have passed, the effects of post-COVID conditions on public health remain. A new study led by Weill Cornell Medicine and NewYork-Presbyterian investigators has found that the risk of long COVID and its symptoms present very differently across diverse populations and suggests that further investigation is needed to accurately define the disease and improve diagnosis and treatment.